参考文献:
[1]GERA M,SHARMA N,GHOSH M,et al.Nanoformulations of Curcumin:an Emerging Paradigm for Improved Remedial Application[J].Oncotarget,2017,8(39):66680-66698.
[2]AHANGARI N,KARGOZAR S,GHAYOUR-MOBARHAN M,et al.Curcumin in Tissue Engineering:a Traditional Remedy for Modern Medicine[J].BioFactors,2019,45(2):135-151.
[3]李雯博,蒋乐章,樊旭,等.姜黄素抑制肝癌细胞HepG2增殖及干细胞标志物表达[J].湖北医药学院学报,2019,38(6):539-543.
[4]周亚宾,华进,戚伶俐,等.姜黄素预处理对急性缺血再灌注模型大鼠肝脏的保护作用[J].吉林大学学报(医学版),2020,46(2):297-301,433.
[5]刘国安,冉苗苗,许欣欣,等.抗氧化与促氧化-姜黄素抗癌机制[J].生命的化学,2019,39(3):472-477.
[6]WEI Y M,PU X L,ZHAO L.Preclinical Studies for the Combination of Paclitaxel and Curcumin in Cancer Therapy(Review)[J].Oncol Rep,2017,37(6):3159-3166.
[7]董淑琦.姜黄素促进自噬改善顺铂所致认知障碍的研究[D].泉州:华侨大学,2019:80.
[8]DAVIS B M, PAHLITZSCH M,GUO L,et al.Topical Curcumin Nanocarriers are Neuroprotective in Eye Disease[J].Scientific Reports,2018,8(1):11066.
[9]徐晓勇,马凤森,黄颖聪.酮咯酸新型制剂的研究进展[J].现代药物与临床,2016,31(1):116-121.
[10]宋亚南.温度诱导的聚(N-异丙基丙烯酰胺)/聚乙烯亚胺微凝胶悬浮液的相转变行为[D].沈阳:沈阳化工大学,2019:48.
[11]李翔,刘亚丽,张鹏,等.姜黄素眼用纳米混悬凝胶剂对大鼠硒性白内障的治疗作用[J].中国实验方剂学杂志,2017,23(22):9-13.
[12]董丹丹,郑岩,刘会珍,等.田蓟苷纳米混悬剂冻干粉缓释片制备工艺研究[J].中草药,2019,50(12):2841-2847.
[13]张雅稚,张洪,彭锐.泊那替尼纳米混悬剂的制备及体外释放度考察[J].广东药学院学报,2014,30(5):544-548.
[14]邹清,谈唯,宁青,等.厚朴酚纳米晶体混悬剂的制备及质量评价[J].中国药房,2019,30(15):2037-2041.
|